Prostatic Malakoplakia as a Mimic of Prostate Cancer Progression
Abstract
Prostatic malakoplakia is a rare chronic inflammatory condition that can present as a cancer mimic and can co-occur with prostate adenocarcinoma. Typically, patients with prostate adenocarcinoma who present with evidence of disease progression while on androgen deprivation therapy (ADT) and a low prostate-specific antigen (PSA) level raise concern for transformation to small cell neuroendocrine carcinoma (SCNEC) of the prostate. A 67-year-old man with known locally advanced prostate adenocarcinoma was admitted with functional decline, radiographic tumor growth, and a low PSA. A repeat prostate biopsy was obtained to assess for transformation to SCNEC, but instead showed concurrent malakoplakia with his stable adenocarcinoma. With antibiotics, his peri-prostatic mass decreased in size, and he experienced an improvement in his functional status, allowing him to resume his ADT. Recurrent urinary tract infections, solid tumors, and immunosuppression are all risk factors for the development of prostatic malakoplakia, which is diagnosed pathologically from biopsy or after prostatectomy. Treatment is either long-term antibiotics or surgical resection. Prostatic malakoplakia should be considered as a mimic of disease progression in patients who have evidence of cancer progression despite a lower-than-expected PSA.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.